Targeting TRPC6 to treat focal segmental glomerulosclerosis (FSGS)
Research Grant
Administered By
Medicine, Nephrology
Awarded By
Amgen, Inc.
Start Date
December 7, 2016
End Date
December 31, 2019
Administered By
Medicine, Nephrology
Awarded By
Amgen, Inc.
Start Date
December 7, 2016
End Date
December 31, 2019